Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4165 reports available
All reports
Page 138 of 174
First Take: FY26 Underlying EBIT In-Line With Expectations
Goldman Sachs · May 18, 2026
Americas Small Cap Research Summary
Barclays · May 18, 2026
Policy Puts vs. Errors
UBS · May 18, 2026
TMT Specialist Sales Update
Goldman Sachs · May 18, 2026
Brambles First Take Trading Update
Goldman Sachs · May 18, 2026
York Space Systems (YSS): Incremental Uncertainty in the Revenue Growth Trajectory
Goldman Sachs · May 18, 2026
Bonds Offer Attractive Risk Return Despite Near Term Volatility
UBS · May 18, 2026
Top Goldman Trader Sees Opportunity in Market Dislocation
Goldman Sachs · May 18, 2026
Asia's Investment Super-Cycle and Competitive Reinvention
Morgan Stanley · May 18, 2026
Trading Catalysts Retail Earnings Wave NVDA and FOMC Minutes
Bank of America · May 18, 2026
Solid Quarter and Incremental eIPP Investment
Goldman Sachs · May 18, 2026
Regeneron Pharmaceuticals Inc. (REGN): Ph3 Anti-LAG-3 Study In First-Line Metastatic Melanoma Fails
Goldman Sachs · May 18, 2026
GS Morning update: Thoughts From the Floor and European Views
Goldman Sachs · May 18, 2026
Global Equities Call
Goldman Sachs & Co. LLC · May 18, 2026
China Consumption Slump and Industrial Divergence
Bloomberg · May 18, 2026
The Best Thing I Read This Weekend
Goldman Sachs · May 18, 2026
Australia Macro Mid-Year Outlook
Morgan Stanley · May 18, 2026
China Equity Strategy: Forging New Horizons
Morgan Stanley · May 18, 2026
Market Colour and Corporate Updates
Goldman Sachs · May 18, 2026
Hudson Pacific Properties 1Q26 Review
Goldman Sachs · May 18, 2026
Earnings Season Monitor: A Strong Season
Morgan Stanley · May 18, 2026
Asia Communacopia and Technology Key Takeaways Longsys
Goldman Sachs · May 18, 2026
Weekly Warm-up Thoughts from the Road
Morgan Stanley · May 18, 2026
First Take: FY26 Trading Update - Revenue/EBIT Guide Lowered
Goldman Sachs · May 18, 2026